Edition:
United Kingdom

GlycoMimetics Inc (GLYC.OQ)

GLYC.OQ on NASDAQ Stock Exchange Global Market

25.25USD
5:23pm GMT
Change (% chg)

$1.21 (+5.03%)
Prev Close
$24.04
Open
$23.95
Day's High
$26.01
Day's Low
$23.71
Volume
94,876
Avg. Vol
172,966
52-wk High
$26.05
52-wk Low
$3.83

Select another date:

Thu, Feb 8 2018

BRIEF-Glycomimetics Enters Agreement With Hovon To Initiate Study Startup Activities For Planned Clinical Trial Of GMI-1271 And Decitabine

* GLYCOMIMETICS ENTERS INTO AGREEMENT WITH HOVON TO INITIATE STUDY STARTUP ACTIVITIES FOR PLANNED CLINICAL TRIAL OF GMI-1271 AND DECITABINE IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML) WHO ARE UNFIT FOR CHEMOTHERAPY

BRIEF-GlycoMimetics qtrly loss per share $‍0.24

* Glycomimetics reports program updates and third quarter 2017 results

BRIEF-GlycoMimetics says files for mixed shelf of upto $250 mln

* GlycoMimetics Inc says files for mixed shelf of upto $250.0 million - SEC filing‍​ Source text: (http://bit.ly/2xOoKE6) Further company coverage:

Select another date: